Clinical trial
Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia…
NCT00063076 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00063076 |
|---|---|
| Title | Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata |
| Official title | A Two Stage Phase II Randomized Bilateral Comparison of Topical Targretin® Gel 1% in Alopecia Areata |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Ligand Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alopecia Areata |
| Intervention type | Drug |
| Interventions | Targretin Gel 1% |
| Enrollment | 46 |
| Start date | May 1, 2003 |
| Primary completion | Oct 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Jun 20, 2003 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: